Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials

被引：9
|
作者：
Blauvelt, Andrew [1 ,2 ]
Thaci, Diamant
Papp, Kim A. [3 ]
Ho, Vincent [4 ]
Ghoreschi, Kamran [5 ,6 ,7 ]
Kim, Byung Soo [8 ]
Miller, Megan [9 ]
Shen, Yaung-Kaung [9 ]
You, Yin [9 ]
Chan, Daphne [10 ]
Yu, Jenny [9 ]
Yang, Ya-Wen [11 ]
Lebwohl, Mark G. [12 ]
Gottlieb, Alice B. [12 ]
Crowley, Jeffrey [13 ]
Foley, Peter [14 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR 97223 USA
[2] Univ Lubeck, Inst & Comprehens Ctr Inflammatory Med, Lubeck, Germany
[3] Alliance Clin Res & Prob Med Res, Waterloo, ON, Canada
[4] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada
[5] Free Univ Berlin, Dept Dermatol Venereol & Allergol, Berlin, Germany
[6] Free Univ Berlin, Berlin, Germany
[7] Humboldt Univ, Berlin Inst Hlth Berlin, Berlin, Germany
[8] Pusan Natl Univ Hosp, Busan, South Korea
[9] Janssen Res & Dev LLC, Spring House, PA USA
[10] Janssen Sci Affairs LLC, Horsham, PA USA
[11] Janssen Pharmaceut Co Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA
[12] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[13] Bakersfield Dermatol & Skin Canc Med Grp, Bakersfield, CA USA
[14] Univ Melbourne, Skin Hlth Inst, St Vincents Hosp Melbourne & Prob Med Res, Carlton, Vic, Australia
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 01期
关键词：
2ND PRIMARY CANCERS; PROSTATE-CANCER; INCREASED RISK; MELANOMA;
D O I：
10.1093/bjd/ljad081
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：132 / 134
页数：3
相关论文
共 50 条
  • [1] Long-term safety of guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials with up to 5 years of treatment
    Blauvelt, Andrew
    Gordon, Kenneth B.
    Griffiths, Christopher E. M.
    Papp, Kim A.
    Foley, Peter
    Song, Michael
    Miller, Megan
    Shen, Yaung-Kaung
    You, Yin
    Ramachandran, Paraneedharan
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB174 - AB174
  • [2] Immunogenicity of Guselkumab among psoriasis patients in VOYAGE 1 and VOYAGE 2
    Reich, K.
    Armstrong, A. W.
    Zhu, Y.
    Miller, M.
    You, Y.
    Shen, Y. -K.
    Yang, Y. W.
    Foley, P.
    Griffiths, C. E. M.
    Strober, B.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 42 - 42
  • [3] Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials
    Blauvelt, Andrew
    Lebwohl, Mark
    Langley, Richard G.
    Rowland, Katelyn
    Yang, Ya-Wen
    Chan, Daphne
    Miller, Megan
    You, Yin
    Yu, Jenny
    Thaci, Diamant
    Foley, Peter
    Papp, Kim A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 274 - 282
  • [4] Guselkumab efficacy and safety through 5 years among psoriasis patients with and without metabolic syndrome at baseline: Results from VOYAGE 1 and VOYAGE 2
    Merola, Joseph F.
    Thaci, Diamant
    Choi, Olivia
    Chan, Daphne
    Yang, Ya-Wen
    Miller, Megan
    You, Yin
    Li, Shu
    Blauvelt, Andrew
    Puig, Luis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB170 - AB170
  • [5] Safety of guselkumab in patients with plaque psoriasis through 2 years: a pooled analysis from VOYAGE 1 and VOYAGE 2
    Reich, K.
    Papp, K.
    Armstrong, A. W.
    Wasfi, Y.
    Jiang, G.
    Shen, Y-K.
    Randazzo, B.
    Song, M.
    Kimball, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E297 - E297
  • [6] FOUR-YEAR EFFICACY AND SAFETY OF GUSELKUMAB IN PSORIASIS PATIENTS WITH AND WITHOUT PSORIATIC ARTHRITIS: A POOLED ANALYSIS FROM VOYAGE 1 AND VOYAGE 2
    Reich, K.
    Dutz, J.
    Foley, P.
    Thaci, D.
    Vender, R.
    Song, M.
    Miller, M.
    You, Y.
    Li, S.
    Shen, Y. K.
    Armstrong, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1673 - 1673
  • [7] Four-Year Efficacy and Safety of Guselkumab in Psoriasis Patients with and Without Psoriatic Arthritis: A Pooled Analysis from VOYAGE 1 and VOYAGE 2
    Reich, Kristian
    Dutz, Jan
    Foley, Peter
    Thaci, Diamant
    Vender, Ron
    Song, Michael
    Miller, Megan
    Yu, Yin
    Li, Shu
    Shen, Yaung-Kaung
    Armstrong, April W.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2
    Byung Soo Kim
    Seong Jin Jo
    SangWoong Youn
    Kristian Reich
    Carine Saadoun
    Chia-Ling Chang
    Ya-Wen Yang
    Yu-Huei Huang
    Tsen-Fang Tsai
    Dermatology and Therapy, 2023, 13 : 2721 - 2737
  • [9] Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2
    Kim, Byung Soo
    Jo, Seong Jin
    Youn, Sangwoong
    Reich, Kristian
    Saadoun, Carine
    Chang, Chia-Ling
    Yang, Ya-Wen
    Huang, Yu-Huei
    Tsai, Tsen-Fang
    DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2721 - 2737
  • [10] Consistency of response across subgroups of patients with psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials
    Blauvelt, Andrew
    Reich, Kristian
    Papp, Kim A.
    Griffiths, Christopher E. M.
    Armstrong, April W.
    Foley, Peter
    Shen, Yaung-Kaung
    Kimball, Alexa B.
    Gordon, Kenneth B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB83 - AB83
12345